PSUSA/00010808/202503
PSUSA/00010808/202503
PSUSA/00010808/202503
Human medicines European public assessment report (EPAR): Tremfya, guselkumab, Date of authorisation: 10/11/2017, Revision: 14, Status: Authorised
Agenda - 1st EMA and European Respiratory Society (ERS) bilateral meeting
Human medicines European public assessment report (EPAR): Piqray, alpelisib, Date of authorisation: 27/07/2020, Revision: 18, Status: Authorised
Human medicines European public assessment report (EPAR): Tafinlar, dabrafenib, Date of authorisation: 26/08/2013, Revision: 38, Status: Authorised
Human medicines European public assessment report (EPAR): Vgenfli, aflibercept, Date of authorisation: 14/08/2025, Status: Authorised
Fighting medicine shortages: It takes a team
EMA partners with healthcare professionals and consumers for #ItTakesATeam medicine shortages campaign
Medicine shortages and availability issues
Veterinary medicines European public assessment report (EPAR): Bravecto TriUNO, fluralaner,moxidectin,pyrantel, Status: Authorised